Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HSD17B3 | P37058 | 6/20 | 0.38 |
| ▸ | PTGES | O14684 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | CENPE | Q02224 | 1/20 | 0.38 |
| ▸ | KIF20B | Q96Q89 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3700879 | 0.89 | KMT2A (0.43) | MEN1KMT2AKDM4EGAAALDH1A1 | |
| SCHEMBL23922349 | 0.84 | ALDH1A1 (0.39) | ELANEMEN1KMT2AKDM4EGAA | |
| SCHEMBL24140139 | 0.81 | ELANE (0.36) | ELANEKMT2AKDM4EALDH1A1CYP3A4 | |
| SCHEMBL26218811 | 0.80 | MEN1 (0.44) | ELANEMEN1KMT2AALDH1A1HSD17B3 | |
| SCHEMBL563659 | 0.79 | ALOX15 (0.54) | ELANEMEN1KMT2AKDM4EGAA | |
| SCHEMBL6914193 | 0.78 | MAPT (0.56) | ELANEMEN1KMT2AKDM4EGAA | |
| SCHEMBL6905774 | 0.78 | MAPT (0.56) | ELANEMEN1KMT2AKDM4EGAA | |
| SCHEMBL6912499 | 0.78 | MAPT (0.56) | ELANEMEN1KMT2AKDM4EGAA | |
| SCHEMBL6907126 | 0.78 | MAPT (0.56) | ELANEMEN1KMT2AKDM4EGAA | |
| SCHEMBL6911155 | 0.78 | MAPT (0.56) | ELANEMEN1KMT2AKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240240160-A1 | NOVEL OLIVETOL SYNTHASES FOR CANNABINOID PRODUCTION | CREO INGREDIENTS, INC. | 2024-07-18 | — | — | US | claimed |
| US-20240052332-A1 | OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE | CREO INGREDIENTS, INC. | 2024-02-15 | — | — | US | claimed |
| US-20230167468-A1 | CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE | CREO INGREDIENTS, INC. | 2023-06-01 | — | — | US | claimed |
| EP-4136220-A1 | CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE | Genomatica, Inc. (US) | 2023-02-22 | — | — | EP | claimed |
| US-20220315969-A1 | OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE | CREO INGREDIENTS, INC. | 2022-10-06 | — | — | US | claimed |
| EP-4025705-A2 | PRENYLTRANSFERASE VARIANTS AND METHODS FOR PRODUCTION OF PRENYLATED AROMATIC COMPOUNDS | Genomatica, Inc. (US) | 2022-07-13 | — | — | EP | claimed |
| WO-2022125645-A1 | OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE | GENOMATICA, INC. (US) | 2022-06-16 | — | — | WO | claimed |
| US-20220177858-A1 | OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS | CREO INGREDIENTS, INC. | 2022-06-09 | — | — | US | claimed |
| EP-3980520-A1 | OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE | Genomatica, Inc. (US) | 2022-04-13 | — | — | EP | claimed |
| EP-3956462-A1 | OLIVETOL SYNTHASE VARIANTS AND METHODS FOR PRODUCTION OF OLIVETOLIC ACID AND ITS ANALOG COMPOUNDS | Genomatica, Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| US-12522849-B2 | Microbial production of cannabinoids | Amyris, Inc. (US) | 2026-01-13 | — | — | US | disclosed |
| US-20250388874-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | GENOMATICA INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250366303-A1 | LIGHT EMITTING ELEMENT, DISPLAY PANEL, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2025-11-27 | — | — | US | disclosed |
| EP-4654807-A1 | LIGHT EMITTING ELEMENT, DISPLAY PANEL, AND ELECTRONIC DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-12480144-B2 | Cannabinoid synthase variants and methods for their use | CREO INGREDIENTS, INC. (US) | 2025-11-25 | — | — | US | disclosed |
| US-20190169661-A1 | GENES AND PROTEINS FOR AROMATIC POLYKETIDE SYNTHESIS | UNIVERSITY OF SASKATCHEWAN (CA) | 2019-06-06 | — | — | US | disclosed |
| US-20170233779-A1 | GENES AND PROTEINS FOR AROMATIC POLYKETIDE SYNTHESIS | UNIVERSITY OF SASKATCHEWAN (CA) | 2017-08-17 | — | — | US | disclosed |
| US-9611460-B2 | Genes and proteins for aromatic polyketide synthesis | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2017-04-04 | — | — | US | disclosed |
| US-20120122180-A1 | INCORPORATION OF TYPE III POLYKETIDE SYNTHASES INTO MULTIDOMAIN PROTEINS OF THE TYPE I AND III POLYKETIDE SYNTHASE AND FATTY ACID SYNTHASE FAMILIES | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2012-05-17 | — | — | US | disclosed |
| US-20080233628-A1 | Incorporation of type III polyketide synthases into multidomain proteins of the type I and III polyketide synthase and fatty acid synthase families | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388874-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | BLVRB, SQOR, CYP2F1 | ELANE 4149/4885MEN1 3893/4885KMT2A 3075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.